AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Resilia Pharmaceuticals Tech Stack and Enterprise Applications

Resilia Pharmaceuticals Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2025 2025
Resilia Pharmaceuticals Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Automattic Legacy WordPress Web Content Management Content Management n/a 2025 2025
Resilia Pharmaceuticals CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Synergistix Legacy Synergistix CATS Software Suite Life Sciences CRM CRM n/a 2023 2023
In 2023 Resilia Pharmaceuticals provisioned the Synergistix CATS Software Suite for CRM and commercial support in the United States. The Synergistix CATS Software Suite is documented in vendor materials and the Synergistix help area, and it is classified under the Life Sciences CRM category for pharmaceutical commercial operations. Vendor documentation and the active Resilia C.A.T.S. tenant referenced in Synergistix support materials imply use of core CATS modules, including CATS CRM and CATS Mobile, as the primary interfaces for commercial teams. Implementation aligns with common Life Sciences CRM capabilities, such as account and contact management, call and activity capture for field engagement, sample and inventory tracking, territory alignment, and mobile field data capture to support point of care interactions and reporting. Deployment is tenant based on the vendor C.A.T.S. platform, indicating a vendor hosted SaaS tenant model that supports Resilia specific configuration and data segregation for U.S. operations. The implementation narrative centers on a cloud delivered application architecture with mobile client support for field users, enabling synchronized field activity and central CRM records. Operational coverage focuses on commercial operations and field sales support, with the Synergistix help center serving as the documented support channel for the Resilia tenant. Governance appears to be oriented around standard CRM adoption practices, including configuration management, user provisioning for field and commercial staff, and centralized administration by Resilia commercial leadership.
Tag Management CRM 2025 2025
Resilia Pharmaceuticals PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Apps Development PaaS 2025 2025
Resilia Pharmaceuticals IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2021 2021
Application Hosting and Computing Services IaaS 2022 2022
Application Hosting and Computing Services IaaS 2025 2025
Content Delivery Network IaaS 2021 2021
Content Delivery Network IaaS 2021 2021
Content Delivery Network IaaS 2024 2024
Resilia Pharmaceuticals CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Security (AppSec) CyberSecurity 2025 2025
Secure Sockets Layer (SSL) CyberSecurity 2021 2021
Secure Sockets Layer (SSL) CyberSecurity 2022 2022
Secure Sockets Layer (SSL) CyberSecurity 2023 2023

IT Decision Makers and Key Stakeholders at Resilia Pharmaceuticals

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Resilia Pharmaceuticals Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Resilia Pharmaceuticals IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Resilia Pharmaceuticals digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Resilia Pharmaceuticals Technographics
Resilia Pharmaceuticals is a Life Sciences organization based in United States, with around 35 employees and annual revenues of $10.0 million.
Resilia Pharmaceuticals operates a diverse technology stack with applications such as Microsoft 365, WordPress and Synergistix CATS Software Suite, covering areas like Collaboration, Web Content Management and Life Sciences CRM.
Resilia Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft, Automattic and Synergistix.
Resilia Pharmaceuticals recently adopted applications including Microsoft 365 in 2025, WordPress in 2025 and Google Tag Manager in 2025, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Resilia Pharmaceuticals’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Resilia Pharmaceuticals’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Resilia Pharmaceuticals technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.